Figure 4. Graphs show the time course for motor impairment, analgesia (thermal withdrawal latency) and change in supraspinal side effects (supraspinal index) expressed in percentage of maximal possible effect for different doses of intrathecal continuous infusion (0.1 micro liter/min) of glycine. Each data point represents the mean and SEM of five or six animals.